# NHS England - Midlands and East Branded Medicines - Tranche B

> Contract award record from UK public-sector procurement sources.

## Key facts

- Public buyer: [NHS England](/buyers/nhs-england/contract-awards)
- Contract winner: Amgen Ltd
- Award value: £295,035,882
- Tender value: £295,035,882
- Award date: 17 January 2019
- Published: 21 March 2019
- Contract start: 1 March 2019
- Contract end: 28 March 2021
- Stage: awarded
- Procurement category: goods
- Notice ID: f56d7e36-a030-4203-9d69-4239426ce665-277481
- OCID: ocds-b5fd17-8aaddf75-dd22-4754-b241-885b44819814

## Description

NHS Framework for the Midlands and East, Branded Medicines - Tranche B, Offer reference number: CM/PHR/16/5524 Period of framework agreement: CM/PHR/16/5524/01 - NHS Framework for the Midlands and East, Branded Medicines - Tranche B - 1 March 2019 to 28 Feb 2021 with an option to extend \(at the Authority's discretion\) for a period or periods up to a total of 24 months CM/PHR/16/5524/02 - NHS Framework for the Midlands and East, Branded Medicines - Tranche B \(Cytokine modulators and other monoclonal antibodies\) - 1 March 2019 to 29 Feb 2020 with an option to extend \(at the Authority's discretion\) for a period or periods up to a total of 12 months

## Related contract awards

- [Transformation Delivery Services - Establishing Operational Excellence \(EOE\)](/contracts/ocds-b5fd17-b08595d2-8961-409b-9b62-7b01d7a64541): NHS England
- [Identity Access Management - Service Adoption and Enablement](/contracts/ocds-b5fd17-08ebad6c-84fb-4e62-9afd-d06d220dd3a5): NHS England
- [OutSystems licenses for MAPPTI \(AP&P\)](/contracts/ocds-b5fd17-521fbf90-6e93-4366-b3bc-47aa2efd447d): NHS England
- [CM/TNS/24/5711 -NHS Framework for the supply of Ustekinumab](/contracts/ocds-b5fd17-bd18e8bf-f1dd-455f-8b23-688c3cad9f30): NHS England
- [NHS National Framework Agreement for the supply of Eculizumab - 1 Feb 2024](/contracts/ocds-b5fd17-f8f31612-30fe-46cd-8155-9f4881ec58c8): NHS England
- [NHS National Framework Agreement for the supply of Adalimumab Injection 1 April 2023](/contracts/ocds-b5fd17-f074e643-f848-4b2d-aec8-e624b3fc10e0): NHS England

## Source

[View the original notice on Contracts Finder](https://www.contractsfinder.service.gov.uk/Notice/f56d7e36-a030-4203-9d69-4239426ce665-277481)